NRC Health Reports Second Quarter 2026 Financial Results

Second Quarter 2026 Results Announced

NRC Health disclosed its financial and operating results for the second quarter ended June 30, 2026, through an announcement on July 28, 2026. The disclosure was made via press release, which was furnished as an exhibit to the company's current report filed with the Securities and Exchange Commission. This quarterly announcement represents the company's regular reporting cadence and provides stakeholders with performance metrics covering the first half of the calendar year.

The press release was issued by executive management on behalf of the Delaware-incorporated company. Shane Harrison, Executive Vice President and Chief Financial Officer, signed the filing on behalf of NRC Health. The announcement follows the company's standard quarterly disclosure procedures and includes financial performance data for the three-month period ending June 30, 2026.

Company Overview and Registration Details

NRC Health is a Delaware corporation trading on the NASDAQ under the ticker symbol NRC. The company maintains its principal executive offices at 1245 Q Street in Lincoln, Nebraska. The organization holds Securities and Exchange Commission Commission File Number 001-35929 and an Internal Revenue Service Employer Identification Number of 47-0634000. These registration details confirm the company's status as a publicly traded entity subject to SEC reporting requirements.

The company's common stock carries a par value of $0.001 per share and is listed on The NASDAQ Stock Market under the trading symbol NRC. NRC Health is not classified as an emerging growth company under Securities Act definitions. The organization maintains standard reporting obligations under the Securities Exchange Act and related federal securities regulations.

Disclosure Format and Filing Status

The announcement was conveyed through a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The press release containing financial and operating results was furnished as Exhibit 99.1 to this report and incorporated by reference. This filing mechanism allows the company to disclose material information while providing investors with access to detailed results through the attached exhibit.

The company clarified that the information contained in the disclosure and related exhibits shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act or incorporated by reference in any other filing under the Securities Act or the Securities Exchange Act, except as expressly set forth by specific reference. This language is standard in quarterly announcements and defines the regulatory scope of the disclosure.

Forward-Looking Statements and Risk Factors

The filing notes that the information provided may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These statements are subject to the safe harbor provisions created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are made based on management's current beliefs and expectations and are subject to significant risks and uncertainties.

The company disclosed that actual results or events may differ from those anticipated by forward-looking statements. Investors seeking comprehensive information regarding risks, uncertainties, and other factors that may affect future results are directed to examine the full press release, the company's stockholder reports, and filings with the Securities and Exchange Commission. These documents provide detailed discussions of potential challenges and contingencies affecting business operations.

Regulatory Compliance and Executive Authorization

The filing was executed by Shane Harrison, who holds the title of Executive Vice President and Chief Financial Officer at NRC Health. Harrison signed the report on July 28, 2026, on behalf of the company, satisfying the execution requirements of the Securities Exchange Act of 1934. This signature represents the authorized officer's certification of the filing's accuracy and completeness under applicable securities laws.

The company confirmed compliance with Securities Exchange Act requirements by duly causing the report to be signed by an authorized representative. This procedural step ensures that the disclosure meets regulatory standards for authentication and reflects appropriate corporate governance controls. The designation of the CFO as the signing officer is typical for quarterly financial announcements and reflects standard corporate practice.

Quarterly Performance Period Coverage

The disclosure period covered by this announcement encompasses the three-month interval ended June 30, 2026. This quarterly measurement aligns with standard calendar-based financial reporting cycles used by publicly traded companies. The second quarter results provide investors with performance metrics covering April, May, and June 2026, offering insight into the first half of the fiscal year.

The specific period end date of June 30, 2026, allows for comparison with prior year results and establishes a consistent measurement framework. This quarterly disclosure pattern enables investors to track operational trends and financial performance across multiple periods, facilitating year-over-year and sequential analysis of company operations.

Exhibit Documentation and Reference Materials

The report includes Exhibit 99.1, which contains the full press release announcing financial and operating results for the second quarter. This exhibit provides comprehensive detail regarding the company's performance metrics, operational developments, and management commentary. Exhibit 104, described as a Cover Page Interactive Data File embedded within the Inline XBRL document, provides machine-readable financial data for regulatory and analytical purposes.

These exhibits serve as supporting documentation to the current report filing, offering investors access to detailed information regarding quarterly performance. The Inline XBRL format (Exhibit 104) enables automated data extraction and comparison, supporting both institutional and individual investor analysis. The press release (Exhibit 99.1) contains narrative commentary and context surrounding the numerical results.

Contact Information and Principal Place of Business

NRC Health's principal executive offices are located at 1245 Q Street, Lincoln, Nebraska 68508. The company maintains a telephone line at (402) 475-2525 for inquiries. These contact details identify the location where corporate management operates and primary business functions are coordinated. The Lincoln-based headquarters reflects the company's operational footprint and serves as the registered office for corporate purposes.

The registration address in Lincoln, Nebraska, combined with the company's NASDAQ listing and SEC registration, confirms NRC Health's status as a fully reported public company subject to comprehensive disclosure obligations. The provision of contact information facilitates communication between the company and its stakeholders regarding financial results and business developments.

Second Quarter 2026 Results: Specific Performance Metrics

The company did not disclose specific financial figures, revenue totals, earnings metrics, or operational statistics within the current report filing itself. The numerical details and performance data are contained exclusively within the attached press release (Exhibit 99.1). This structure is standard for quarterly announcements, where the current report serves as the regulatory vehicle for disclosure, while the press release provides the substantive financial and operational information.

Investors seeking detailed information regarding revenue, earnings per share, operating margins, segment performance, or other specific metrics should consult the full press release attached as Exhibit 99.1. That document contains the comprehensive financial results and management analysis covering the three-month period ended June 30, 2026. The press release typically includes period-over-period comparisons, management guidance commentary, and operational highlights.

Investor Considerations and Information Sources

This announcement represents NRC Health's scheduled quarterly disclosure to the investment community and regulatory authorities. Investors analyzing the company's performance should review the complete press release and examine trends across multiple quarterly periods to develop comprehensive understanding of operational trajectory. The filing indicates that forward-looking statements carry risk and that actual results may diverge from management expectations or projections.

Shareholders and prospective investors interested in understanding NRC Health's strategic direction, competitive position, and financial outlook should examine the company's most recent stockholder reports and Securities and Exchange Commission filings. These documents provide contextual information regarding business operations, market conditions, competitive dynamics, and management's assessment of future opportunities and challenges. The safe harbor language in the filing indicates that management commentary should be evaluated with awareness of inherent uncertainties in forward-looking projections.